Northwest Bancshares Inc. Grows Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Northwest Bancshares Inc. lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,444 shares of the pharmaceutical company’s stock after purchasing an additional 357 shares during the period. Vertex […]

Related Keywords

Canada ,Sangeetan Bhatia ,Kristen Ambrose ,Bancshares Inc ,Nasdaq ,Quarter For Vertex Pharmaceuticals ,Morgan Stanley ,Vertex Pharmaceuticals Stock Down ,Insider Activity At Vertex Pharmaceuticals ,Schechter Investment Advisors ,Vertex Pharmaceuticals ,Wells Fargo Company ,Securities Exchange Commission ,Maxim Group ,Davis Investment Partners ,Vertex Pharmaceuticals Incorporated ,Exchange Commission ,Penserra Capital Management ,Sequoia Financial Advisors ,Royal Bank ,News Ratings For Vertex Pharmaceuticals Daily ,Northwest Bancshares ,Free Report ,Financial Advisors ,Capital Management ,Investment Advisors ,Investment Partners ,Director Sangeeta ,Pharmaceuticals Stock Down ,Pharmaceuticals Incorporated ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,